arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Charlie's Holdings, Inc.

CHUC
— Price unavailable
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
17 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
58
Health
Fair
Moderately Bullish
auto_awesome

Analytical Summary

Charlie's Holdings, Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Operating Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap —
Dividend Yield —
Revenue Growth 169.4% ↗
Op. Margin -10.4% ↗
ROIC -59.5% ↘
FCF / Share $-0.02 ↘
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$20.92M
↑ +169.4% —
Net Income Profit after all expenses
$4.50M
↑ +208.2% —
Operating Margin Operating profit as % of sales
-10.4%
↑ +75.7% 15th
FCF / Share Free cash flow per share
$-0.02
↓ -226.5% —
Long-Term Debt Long-term obligations
$2.46M
↑ +69.9% —
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
35
Returns ↑
100
Cash Quality ↓
9

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 67 quarters